GAYA IN AFRICA
BY AFRICANS, FOR AFRICA
Innovation • Excellence • Impact
Our Expertise in Africa
By Africans, For Africa
At Gaya Pharma, we believe that Africa's future in healthcare and clinical research must be driven by Africans, rooted in the realities of the continent, and built on sustainable collaboration with local communities and institutions. We are not just present in Africa—we are of Africa, with our headquarters in Morocco and a growing network of subsidiaries dedicated to serving the continent more effectively.
Our Journey
Our journey began over a decade ago, when Gaya Pharma positioned itself as a pioneering full-service Contract Research Organization (CRO) in North Africa. Today, with the launch of Gaya Pharma CI in Abidjan, we are extending our reach to West Africa, a region with extraordinary potential and an increasing demand for clinical research, real-world evidence (RWE) studies, and patient access programs.
Rabat, Morocco
Headquarters - North Africa Hub
Abidjan, Côte d'Ivoire
Gaya Pharma CI - West Africa Hub
A Pan-African Presence to Serve Better
Africa is diverse, complex, and dynamic. To serve it well, one needs more than just global standards—one needs local insight, cultural understanding, and a true sense of belonging.
North Africa Operations
From our base in Rabat, Morocco, we have successfully managed clinical trials, patient support programs, and real-world evidence studies in partnership with both local institutions and international pharmaceutical companies.
West Africa Expansion
With Gaya Pharma CI in Côte d'Ivoire, we now cover the heart of West Africa, ensuring that our services are closer to stakeholders, regulators, hospitals, and patients in this vital region.
This dual presence allows us to act as a continental bridge: combining international expertise with an African vision, ensuring that clinical research and healthcare innovation are not only introduced into Africa, but also shaped by Africa.
Advanced Data Collection Tailored to African Realities
One of Gaya Pharma's strongest assets lies in its ability to leverage advanced methodologies for data collection and analysis, while fully adapting to the African context.
We integrate cutting-edge digital solutions—such as electronic case report forms (e-CRF), secure data platforms, interactive dashboards, and mobile health technologies—with a deep understanding of local environments.
This unique approach allows us to:
🎯 Scientific Rigor
Ensure scientific rigor and compliance with global standards
🌐 Local Adaptation
Adapt to infrastructural realities, including rural or underserved regions with limited connectivity
📊 Real-Time Visibility
Provide real-time visibility of studies and patient outcomes, empowering decision-makers with actionable insights
🤝 Trust Building
Build trust among patients and healthcare professionals by offering systems designed in line with their specific needs
By combining global best practices with local adaptability, Gaya Pharma ensures that African data is not only reliable but also meaningful for shaping better health policies and patient care.
Promoting Clinical Research and Access to Healthcare
Our commitment goes beyond delivering services—we are actively contributing to Africa's emergence as a global player in clinical research.
Through our work, we seek to:
- Expand patient access to innovative treatments and therapies across the continent
- Train and empower African healthcare professionals, strengthening local capacity and expertise
- Facilitate knowledge transfer between global pharmaceutical leaders and African institutions
- Promote evidence-based healthcare policies, driven by robust local and regional data
With every project, whether it is a multinational clinical trial, an observational study, or a patient support program, we aim to create lasting impact—for patients, for health systems, and for African scientific visibility worldwide.
Gaya Pharma CI: Serving West Africa with Excellence
The launch of Gaya Pharma CI in Abidjan represents more than an expansion—it is a strategic milestone in our vision. Côte d'Ivoire, as a hub for West Africa, offers an excellent platform to serve not only Ivorian patients and professionals but also the broader region, including neighboring countries where healthcare challenges and opportunities are immense.
With Gaya Pharma CI, we are committed to:
- Building closer collaborations with West African hospitals, universities, and ministries of health
- Supporting regional and international pharmaceutical companies in conducting high-quality, context-adapted clinical research
- Implementing patient access programs that address local realities, including affordability, availability, and education
- Acting as a center of excellence for West Africa, where science, technology, and healthcare delivery converge
An African CRO for an African Future
At Gaya Pharma, we stand out because we are not an external player trying to enter Africa's health ecosystem—we are part of it. We understand its challenges, we respect its diversity, and we believe in its potential.
We envision an Africa where clinical research thrives, where patients have fair access to innovation, and where local expertise shapes global health narratives.
With Gaya Pharma CI strengthening our West African footprint and our continued operations across North Africa, we are more determined than ever to build a future where Africa is not just a beneficiary of research, but a global leader in health innovation.
"By Africans, For Africa"